Evidence map›Paper›PMID 40690448›Full record

ArticlePloS one2025

Analysis of aPTT predictors after unfractionated heparin administration in intensive care units using machine learning models.

Tadashi Kamio, Masaru Ikegami, Megumi Mizuno, Seiichiro Ishii, Hayato Tajima, Yoshihito Machida, Kiyomitsu Fukaguchi

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tadashi KamioDepartment of Anesthesiology and Critical Care Medicine, Jichi Medical University Saitama Medical Center, Saitama, Japan.ORCID https://orcid.org/0000-0002-8987-0103
Masaru IkegamiTerumo Corporation, Shonan Center, Ashigarakami-gun, Kanagawa, Japan.
Megumi MizunoTerumo Corporation, Shonan Center, Ashigarakami-gun, Kanagawa, Japan.
Seiichiro IshiiTerumo Corporation, Shonan Center, Ashigarakami-gun, Kanagawa, Japan.
Hayato TajimaTerumo Corporation, Shonan Center, Ashigarakami-gun, Kanagawa, Japan.
Yoshihito MachidaTerumo Corporation, Shonan Center, Ashigarakami-gun, Kanagawa, Japan.
Kiyomitsu FukaguchiDepartment of Critical Care Medicine, Shonan Kamakura General Hospital, Kamakura, Kanagawa, Japan.ORCID https://orcid.org/0000-0003-2262-1898

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesPredicting optimal coagulation control using heparin in intensive care units (ICUs) remains a significant challenge. This study aimed to develop a machine learning (ML) model to predict activated partial thromboplastin time (aPTT) in ICU patients receiving unfractionated heparin for anticoagulation and to identify key predictive factors.

methodsData were obtained from the Tokushukai Medical Database, covering six hospitals with ICUs in Japan, collected between 2018 and 2022. The study included 945 ICU patients who received unfractionated heparin. The dataset comprised both static and dynamic features, which were used to construct and train ML models. Models were developed to predict aPTT following initial and multiple heparin doses. Model performance was evaluated using the area under the receiver operating characteristic curve (ROC AUC), area under the precision-recall curve (PR AUC), precision, recall, F1 score, and accuracy. SHAP analysis was conducted to determine key predictive factors.

resultsThe random forest model demonstrated the highest predictive performance, with ROC AUC values of 0.707 for the first infusion and 0.732 for multiple infusions. Corresponding PR AUC values were 0.539 and 0.551. Despite moderate overall predictive performance, the model exhibited high precision (0.585 for the first infusion and 0.589 for multiple infusions), indicating effectiveness in correctly identifying true positive cases. However, recall and F1 scores were lower, suggesting that some cases, particularly in sub-therapeutic and supra-therapeutic ranges, may have been missed. Incorporating time-series data, such as vital signs, provided only marginal improvements in performance.

conclusionsML models demonstrated moderate performance in predicting aPTT following heparin infusion in ICU patients, with the random forest model achieving the highest classification accuracy. Although the models effectively identified true positive cases, their overall predictive performance remained limited, necessitating further refinement. The inclusion of static and dynamic features did not significantly enhance model accuracy. Future studies should explore additional factors to improve predictive models for optimizing individualized anticoagulation management in ICUs.

Indexed as

AnticoagulantsHeparinMachine LearningAgedFemaleHumansIntensive Care UnitsJapanMaleMiddle AgedPartial Thromboplastin TimeROC CurveAnticoagulantsHeparin

Identifiers

PMID40690448
PMCPMC12279130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.